Publications
I do not have a lot of publications yet, but I hope that the ones I have right now are of interest for you. If you have any questions or are interested in commenting my work I will be happy to receive any comments.
1.
Chorro, Francisco J.; Alonso-Arroyo, Adolfo; Font-Julian, Cristina I.; Liu, Yiming; Aleixandre-Benavent, R.
Characteristics and evolution of the granting of patents in the cardiovascular area in Spain Journal Article
In: REC: CardioClinics, 2025, ISSN: 2605-1532.
Abstract | Links | BibTeX | Tags: Cardiovascular Diseases, Intellectual Property, Inventions, Patent, Research and Development
@article{nokey,
title = {Characteristics and evolution of the granting of patents in the cardiovascular area in Spain},
author = {Francisco J. Chorro and Adolfo Alonso-Arroyo and Cristina I. Font-Julian and Yiming Liu and R. Aleixandre-Benavent},
doi = {https://doi.org/10.1016/j.rccl.2025.08.004},
issn = {2605-1532},
year = {2025},
date = {2025-09-20},
urldate = {2025-09-20},
journal = {REC: CardioClinics},
abstract = {Introduction and objectives
Updated analysis of patent grants related to cardiovascular diseases (CVD) in Spain.
Methods
Development of a search process for patents related to CVD in the Global Patent Index, review of those granted in Spain, and standardization. Analysis of their evolution over time, origin, collaborations, types, and thematic distribution.
Results
Identification of 1870 patents (1909-2023), whose growth has been exponential (n=1.687 exp [0.066*years; P<.001). They come from 1107 applicants from 39 countries, 616 from Spain who have originated 923 patents, followed by Germany (293), Switzerland (177), France (92) and the Netherlands (81). Collaborations are present in 15.2%. Seven networks have involved ≥ 3 applicants with ≥ 2 collaborations. The most frequent subject has been “pharmacological treatments” (38%), and in this group “antihypertensives”. Since 1992, translations of European patents have increased, and are currently the most common type. The proportions by thematic group have varied significantly (P<.001), with more recent increases in those related to “catheters/devices” and “diagnostic/monitoring techniques” and decreases in “pharmacological treatments” and “biochemistry/molecular biology”.
Conclusions
Patents related to CVD in Spain originate mainly in Europe. 15.2% are requested in collaboration. The highest number corresponds to Spain, followed by Germany, Switzerland, France, and the Netherlands. The most frequent subject has been “antihypertensive treatments”. Overall, the largest increase in grants (close to 40%) occurred in the decade 2010-2020, especially related to the translation of European patents. The subjects that are growing the most in the 21st century are those related to “catheters/devices” and “diagnostic/monitoring techniques”.},
keywords = {Cardiovascular Diseases, Intellectual Property, Inventions, Patent, Research and Development},
pubstate = {published},
tppubtype = {article}
}
Introduction and objectives
Updated analysis of patent grants related to cardiovascular diseases (CVD) in Spain.
Methods
Development of a search process for patents related to CVD in the Global Patent Index, review of those granted in Spain, and standardization. Analysis of their evolution over time, origin, collaborations, types, and thematic distribution.
Results
Identification of 1870 patents (1909-2023), whose growth has been exponential (n=1.687 exp [0.066*years; P<.001). They come from 1107 applicants from 39 countries, 616 from Spain who have originated 923 patents, followed by Germany (293), Switzerland (177), France (92) and the Netherlands (81). Collaborations are present in 15.2%. Seven networks have involved ≥ 3 applicants with ≥ 2 collaborations. The most frequent subject has been “pharmacological treatments” (38%), and in this group “antihypertensives”. Since 1992, translations of European patents have increased, and are currently the most common type. The proportions by thematic group have varied significantly (P<.001), with more recent increases in those related to “catheters/devices” and “diagnostic/monitoring techniques” and decreases in “pharmacological treatments” and “biochemistry/molecular biology”.
Conclusions
Patents related to CVD in Spain originate mainly in Europe. 15.2% are requested in collaboration. The highest number corresponds to Spain, followed by Germany, Switzerland, France, and the Netherlands. The most frequent subject has been “antihypertensive treatments”. Overall, the largest increase in grants (close to 40%) occurred in the decade 2010-2020, especially related to the translation of European patents. The subjects that are growing the most in the 21st century are those related to “catheters/devices” and “diagnostic/monitoring techniques”.
Updated analysis of patent grants related to cardiovascular diseases (CVD) in Spain.
Methods
Development of a search process for patents related to CVD in the Global Patent Index, review of those granted in Spain, and standardization. Analysis of their evolution over time, origin, collaborations, types, and thematic distribution.
Results
Identification of 1870 patents (1909-2023), whose growth has been exponential (n=1.687 exp [0.066*years; P<.001). They come from 1107 applicants from 39 countries, 616 from Spain who have originated 923 patents, followed by Germany (293), Switzerland (177), France (92) and the Netherlands (81). Collaborations are present in 15.2%. Seven networks have involved ≥ 3 applicants with ≥ 2 collaborations. The most frequent subject has been “pharmacological treatments” (38%), and in this group “antihypertensives”. Since 1992, translations of European patents have increased, and are currently the most common type. The proportions by thematic group have varied significantly (P<.001), with more recent increases in those related to “catheters/devices” and “diagnostic/monitoring techniques” and decreases in “pharmacological treatments” and “biochemistry/molecular biology”.
Conclusions
Patents related to CVD in Spain originate mainly in Europe. 15.2% are requested in collaboration. The highest number corresponds to Spain, followed by Germany, Switzerland, France, and the Netherlands. The most frequent subject has been “antihypertensive treatments”. Overall, the largest increase in grants (close to 40%) occurred in the decade 2010-2020, especially related to the translation of European patents. The subjects that are growing the most in the 21st century are those related to “catheters/devices” and “diagnostic/monitoring techniques”.